Navigation Links
New Topical Patent Research Reports Recently Published at MarketPublishers.com
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd informs that new in-demand market reports featuring drugs patent researches have been added to its catalogue "Drugs & Biotechnology."

Each of the recently published reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

New market patent research reports include:

  • Sevelamer - Comprehensive Patent Search
  • Sildenafil - Comprehensive Patent Search
  • Silodosin - Comprehensive Patent Search
  • Sorafenib - Comprehensive Patent Search
  • Sunitinib - Comprehensive Patent Search
  • Tadalafil - Comprehensive Patent Search
  • Tazobactam - Comprehensive Patent Search
  • Tenofovir - Comprehensive Patent Search
  • Terbinafine - Comprehensive Patent Search
  • Ulipristal - Comprehensive Patent Search
  • Valaciclovir - Comprehensive Patent Search
  • Varenicline - Comprehensive Patent Search
  • Voriconazole - Comprehensive Patent Search

  • Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • Patent categories identified in each report encompass molecular form, active ingredient preparation, formulations & methods thereof, related medical use & administration, active ingredient combinations, analytical methods.

    More new recent market research reports on Drugs & Biotechnology can be found at http://marketpublishers.com/catalog/drugs_biotechnology.htmlCONTACTSThe Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 123 2220Fax: +44 207 900 3970ps@marketpublishers.comwww.marketpublishers.com
    '/>"/>

    SOURCE The Market Publishers, Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
    2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    3. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
    4. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
    5. Topical erectile dysfunction therapy shows promise
    6. Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
    7. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
    8. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
    9. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
    10. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
    11. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
    (Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
    (Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
    (Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
    Breaking Biology Technology:
    (Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being ... microbiome—the bacteria that live in and on the human body –and are ... The Microbiome ... the human microbiome, starting with the gut. The project's goal is to ... Photo credit: IBM ...
    (Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
    (Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
    Breaking Biology News(10 mins):